Browse Pet Safety Reports
1,329,678 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 1,329,678 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 1,329,678 FDA veterinary adverse event reports.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 19, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Vomiting; Foaming at the mouth | Recovered/Normal |
| Nov 19, 2025 | — | Unknown | Maropitant | Closure, Abnormal; Product defect, product difficult to use/handle (see also ... | — |
| Nov 19, 2025 | Dog | Shepherd Dog - Australian, ... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia | Ongoing |
| Nov 19, 2025 | Cat | Domestic Shorthair | Lotilaner | Death | Died |
| Nov 19, 2025 | Dog | Retriever - Golden, Poodle ... | Febantel,Praziquantel,Pyrantel Embonate | Vomiting | Recovered/Normal |
| Nov 19, 2025 | Cat | Domestic Longhair | Eprinomectin; Praziquantel; Esafoxolaner | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Nov 19, 2025 | Cat | Domestic Shorthair | Sirolimus | Lethargy (see also Central nervous system depression in Neurological); Decrea... | Ongoing |
| Nov 19, 2025 | Dog | Terrier - Yorkshire | Milbemycin/Lufenuron Tablets | Lack of efficacy (endoparasite) - heartworm; Drug dose omission | Ongoing |
| Nov 19, 2025 | Dog | Chihuahua | Sarolaner | Twitching; Ataxia; Overdose | Ongoing |
| Nov 19, 2025 | Cat | Cat (unknown) | Velagliflozin Proline Monohydrate | Diarrhoea | Outcome Unknown |
| Nov 19, 2025 | Cat | Domestic Shorthair | Selamectin;Sarolaner | Application site lesion; Application site hair loss; Skin lesion NOS; Applica... | Ongoing |
| Nov 19, 2025 | Dog | Retriever - Labrador | Pyrantel Pamoate;Sarolaner | Collapse NOS (see also Cardio-vascular and Neurological disorders); Weakness;... | Recovered/Normal |
| Nov 19, 2025 | Horse | Standardbred - American | Furosemide Injection | Increased sweating; Prolonged capillary refill time; Pale mucous membrane; Colic | Recovered/Normal |
| Nov 18, 2025 | Dog | Spaniel - King Charles Cava... | Afoxolaner 18.75Mg / Moxidectin 90Mcg... | Lack of efficacy (bacteria) - Borrelia | Outcome Unknown |
| Nov 18, 2025 | Dog | Retriever - Labrador | Afoxolaner | Lack of efficacy (bacteria) - Anaplasma; Lack of efficacy (ectoparasite) - ti... | Ongoing |
| Nov 18, 2025 | Dog | Retriever - Labrador | Moxidectin | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 18, 2025 | Dog | Crossbred Canine/dog | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 18, 2025 | Dog | Terrier - Jack Russell | Bedinvetmab | Bruising; Thrombocytopenia | Ongoing |
| Nov 18, 2025 | Dog | Retriever - Labrador | Afoxolaner 150Mg / Moxidectin 720Mcg ... | Seizure NOS; Lateral recumbency; Stiffness NOS; Paddling | Recovered/Normal |
| Nov 18, 2025 | Dog | Retriever - Golden, Poodle ... | Florfenicol; Mometasone Furoate; Terb... | Increased appetite; Increased drinking; Pacing | Outcome Unknown |
| Nov 18, 2025 | Dog | Mastiff (unspecified), Dog ... | Bedinvetmab | Urinary incontinence | Ongoing |
| Nov 18, 2025 | Cat | Domestic Shorthair | Capromorelin | Lateral recumbency; Hypotension; Nausea; Abdominal effusion; Other abnormal t... | Euthanized |
| Nov 18, 2025 | Dog | Retriever - Labrador | Lotilaner,Moxidectin,Praziquantel,Pyr... | Vomiting; Loose stool; Product defect NOS | Recovered/Normal |
| Nov 18, 2025 | Dog | Retriever - Labrador, Cross... | Ivermectin; Pyrantel As Pamoate Salt | Lack of efficacy (endoparasite) - hookworm | Outcome Unknown |
| Nov 18, 2025 | Cat | Cat (other) | Frunevetmab | Skin sore; Scratching; Haemorrhage NOS | Ongoing |
| Nov 18, 2025 | Dog | Collie (unspecified) | Afoxolaner 18.75Mg / Moxidectin 90Mcg... | Lack of efficacy (endoparasite) - tapeworm | Ongoing |
| Nov 18, 2025 | Dog | Retriever - Labrador | Ivermectin; Pyrantel Pamoate | Lack of efficacy (endoparasite) - heartworm | Outcome Unknown |
| Nov 18, 2025 | Dog | Terrier - Yorkshire | Afoxolaner 18.75Mg / Moxidectin 90Mcg... | Unclassifiable adverse event | Outcome Unknown |
| Nov 18, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Ketosis | Ongoing |
| Nov 18, 2025 | Dog | Retriever - Labrador | Milbemycin/Lufenuron/Pzq Chew | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 18, 2025 | Cat | Domestic Shorthair | Velagliflozin Proline Monohydrate | Chronic kidney disease | Outcome Unknown |
| Nov 18, 2025 | Dog | Boxer (German Boxer), Dog (... | Bedinvetmab | Paraplegia; Vocalisation; Unconscious; Death by euthanasia | Euthanized |
| Nov 18, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Lack of efficacy (endoparasite) - tapeworm; Lack of efficacy (endoparasite) -... | Outcome Unknown |
| Nov 18, 2025 | Dog | Mixed (Dog) | Afoxolaner 75Mg / Moxidectin 360Mcg /... | Lack of efficacy (endoparasite) - tapeworm | Ongoing |
| Nov 18, 2025 | Dog | Dog (unknown) | Nitenpyram | Lack of efficacy (ectoparasite) - flea | Outcome Unknown |
| Nov 18, 2025 | Cat | Domestic Shorthair | Molidustat Sodium | Loss of vision; Abnormal menace reflex test; High blood pressure; Retinal deg... | Outcome Unknown |
| Nov 18, 2025 | Dog | Dog (unknown) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Anaplasma; Lack of efficacy (ectoparasite) - ti... | Outcome Unknown |
| Nov 18, 2025 | Dog | Coonhound - Treeing Walker | Oclacitinib Maleate | Intentional misuse; Lack of efficacy - NOS | Ongoing |
| Nov 18, 2025 | Dog | Terrier (unspecified) | Tigilanol Tiglate | Lack of efficacy (neoplasia, no remission) | Outcome Unknown |
| Nov 18, 2025 | Dog | Retriever - Labrador | Butorphanol Tartrate | Injection site pain; Intentional misuse; Overdose; Medication error NOS; Deat... | Euthanized |
| Nov 18, 2025 | Dog | Retriever - Labrador, Poodl... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Nov 18, 2025 | Dog | Great Pyrenees | Pyrantel Pamoate;Sarolaner | Intentional misuse; Lack of efficacy (bacteria) - Borrelia; Lack of efficacy ... | Ongoing |
| Nov 18, 2025 | Dog | Setter - English | Oclacitinib Maleate | Elevated serum alkaline phosphatase (ALP); Elevated triglyceride | Ongoing |
| Nov 18, 2025 | Dog | Terrier - Jack Russell, Dog... | Bedinvetmab | Injection site swelling | Recovered/Normal |
| Nov 18, 2025 | Dog | Dog (other) | Pyrantel Pamoate;Sarolaner | Lack of efficacy (bacteria) - Borrelia; Lack of efficacy (bacteria) - Anaplas... | Ongoing |
| Nov 18, 2025 | Dog | Shepherd Dog - Australian | Moxidectin | Lack of efficacy (endoparasite) - hookworm | Ongoing |
| Nov 18, 2025 | Dog | Terrier (unspecified), Dog ... | Pyrantel Pamoate;Sarolaner | Lack of efficacy (endoparasite) - heartworm | Ongoing |
| Nov 18, 2025 | Cat | Domestic Shorthair | Maropitant Citrate | Anorexia; Death; Suspected transmission of a vaccine strain; Intentional misuse | Died |
| Nov 18, 2025 | Cat | Domestic Shorthair | Eprinomectin; Praziquantel; Esafoxolaner | Application site scratching; Application site hair loss | Outcome Unknown |
| Nov 18, 2025 | Dog | Bloodhound, Retriever - Lab... | Pyrantel Pamoate;Sarolaner | Lying down; Drooling; Drunken gait; Unable to walk; Difficulty going up/down ... | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.